bf/NASDAQ:BIIB_icon.jpeg

COM:BIOGEN

Biogen Inc.

  • Stock

USD

Last Close

158.01

22/11 21:00

Market Cap

33.89B

Beta: -

Volume Today

1.70M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
553.19M
-
731.51M
32.24%
848.71M
16.02%
947.50M
11.64%
952.15M
0.49%
916.30M
3.77%
867.05M
5.37%
936.40M
8.00%
1.21B
29.22%
1.35B
11.40%
average payables
211.96M
-
224.55M
5.94%
248.29M
10.57%
273.60M
10.19%
337.65M
23.41%
383M
13.43%
450.65M
17.66%
492.85M
9.36%
522.05M
5.92%
540.35M
3.51%
average receivables
755.63M
-
1.06B
40.07%
1.26B
19.02%
1.33B
5.92%
1.61B
20.98%
1.87B
16.01%
1.92B
2.50%
1.90B
1.16%
1.73B
8.73%
1.84B
6.43%
book value per share
36.39
-
45.75
25.74%
40.64
11.18%
55.53
36.66%
59.26
6.70%
63.60
7.33%
71.29
12.10%
66.41
6.84%
73.51
10.68%
92.14
25.36%
capex per share
-14.81
-
-1.22
91.78%
-2.79
128.94%
-3.33
19.55%
-9.23
177.09%
-4.32
53.16%
-3.58
17.26%
-3.43
4.16%
-1.98
42.33%
-1.67
15.37%
capex to depreciation
-6.60
-
-0.42
93.66%
-1.07
156.12%
-1.07
0.47%
-1.82
70.34%
-0.87
52.00%
-0.98
12.86%
-1.21
22.69%
-0.60
49.90%
-0.47
22.42%
capex to operating cash flow
-1.50
-
-0.10
93.46%
-0.17
76.92%
-0.16
7.00%
-0.43
168.03%
-0.14
66.80%
-0.09
33.95%
-0.13
37.93%
-0.08
37.90%
-0.18
116.84%
capex to revenue
-0.51
-
-0.03
94.14%
-0.06
101.44%
-0.06
6.40%
-0.16
151.59%
-0.07
58.81%
-0.05
29.31%
-0.04
11.86%
-0.03
34.57%
-0.02
10.98%
0.03
217.81%
cash per share
5.16
-
7.81
51.28%
14.86
90.35%
22.41
50.82%
17.35
22.58%
17.27
0.49%
23.92
38.54%
16.22
32.19%
25.50
57.21%
33.67
32.04%
days of inventory on hand
280.43
-
250.61
10.64%
262.89
4.90%
247.23
5.96%
202.14
18.24%
186.87
7.55%
150.11
19.67%
216.06
43.93%
233.82
8.22%
215.38
7.89%
days payables outstanding
93.58
-
71.43
23.67%
78.69
10.15%
69.07
12.23%
88.56
28.23%
74.45
15.93%
99.08
33.07%
91.98
7.17%
101.94
10.83%
78.74
22.75%
days sales outstanding
43.41
-
48.62
12.00%
41.61
14.42%
45.96
10.46%
53.14
15.63%
53.14
0.01%
47.74
10.16%
51.96
8.84%
51.50
0.88%
76.65
48.84%
debt to assets
0.05
-
0.04
18.63%
0.33
718.58%
0.28
14.86%
0.25
11.88%
0.23
6.50%
0.23
0.40%
0.32
36.00%
0.32
0.15%
0.27
15.41%
debt to equity
0.07
-
0.05
21.72%
0.70
1,186.43%
0.54
22.81%
0.47
12.28%
0.46
3.35%
0.48
4.79%
0.73
53.46%
0.69
5.30%
0.49
28.79%
dividend yield
1.01
-
0.68
32.14%
0.08
87.72%
0.00
-
0.00
83.24%
earnings yield
0.03
-
0.04
30.10%
0.05
37.20%
0.06
19.13%
0.04
37.29%
0.07
91.68%
0.11
47.60%
0.10
4.26%
0.04
57.16%
0.08
74.08%
enterprise value
66.23B
-
79.61B
20.21%
75.89B
4.68%
66.12B
12.87%
72.09B
9.03%
66.37B
7.93%
58.97B
11.15%
45.89B
22.17%
41.11B
10.42%
43.43B
5.64%
enterprise value over ebitda
23.59
-
18.30
22.43%
13.74
24.89%
10.11
26.46%
11.05
9.28%
9.67
12.42%
7.84
18.93%
9.55
21.72%
11.24
17.77%
16.17
43.80%
ev to operating cash flow
28.24
-
27.06
4.19%
20.42
24.53%
14.62
28.41%
15.84
8.34%
10.73
32.29%
8.33
22.33%
10.85
30.24%
11.30
4.10%
31.37
177.76%
ev to sales
9.55
-
8.20
14.12%
7.05
14.07%
5.78
18.09%
5.87
1.70%
4.93
16.00%
4.10
16.86%
3.41
16.77%
3.74
9.67%
4.27
14.03%
free cash flow per share
-4.91
-
11.23
328.59%
13.32
18.62%
17.38
30.44%
12.17
29.93%
25.87
112.53%
34.25
32.39%
22.86
33.27%
22.43
1.86%
7.85
64.99%
free cash flow yield
-0.02
-
0.03
288.27%
0.04
31.43%
0.06
40.91%
0.04
37.63%
0.09
125.00%
0.12
34.26%
0.09
19.13%
0.09
0.16%
0.03
69.67%
graham net net
-4.52
-
-1.21
73.28%
-23.12
1,812.35%
-19.56
15.42%
-26.22
34.06%
-33.12
26.31%
-40.66
22.77%
-58.13
42.98%
-48.81
16.04%
-27.52
43.62%
graham number
80.22
-
113.06
40.93%
118.57
4.87%
145.55
22.76%
126.19
13.30%
175.91
39.40%
224.69
27.73%
192.76
14.21%
131.38
31.84%
208.51
58.70%
income quality
1.26
-
1.00
20.57%
1.03
3.40%
1.22
18.32%
1.70
39.29%
1.38
18.86%
1.20
13.08%
1.04
13.34%
2.11
102.26%
0.47
77.82%
intangibles to total assets
0.48
-
0.40
15.96%
0.35
14.43%
0.33
5.53%
0.36
10.10%
0.35
3.02%
0.34
2.32%
0.36
5.40%
0.33
6.96%
0.31
7.43%
0
100%
interest coverage
78.86
-
134.66
70.76%
51.21
61.97%
19.81
61.32%
21.31
7.57%
29.35
37.76%
37.58
28.02%
20.45
45.58%
11.20
45.22%
9.41
16.00%
interest debt per share
2.65
-
2.60
1.86%
28.70
1,003.67%
31.03
8.11%
29.11
6.19%
29.95
2.89%
35.03
16.97%
50.04
42.82%
52.70
5.32%
47.22
10.40%
inventory turnover
1.30
-
1.46
11.90%
1.39
4.67%
1.48
6.33%
1.81
22.31%
1.95
8.17%
2.43
24.49%
1.69
30.52%
1.56
7.60%
1.69
8.56%
invested capital
0.07
-
0.05
21.72%
0.70
1,186.43%
0.54
22.81%
0.47
12.28%
0.46
3.35%
0.48
4.79%
0.73
53.46%
0.69
5.30%
0.49
28.79%
market cap
66.24B
-
80.23B
21.13%
70.67B
11.91%
61.93B
12.37%
67.73B
9.36%
61.66B
8.96%
55.52B
9.96%
39.40B
29.04%
35.77B
9.20%
40.24B
12.48%
net current asset value
-57.56M
-
1.17B
2,132.82%
-3.43B
393.09%
-2.02B
41.22%
-3.18B
57.80%
-4.62B
45.12%
-5.51B
19.43%
-7.05B
27.79%
-5.06B
28.17%
-1.37B
72.84%
net debt to ebitda
-0.00
-
-0.14
5,927.17%
0.94
762.91%
0.64
32.23%
0.67
4.42%
0.69
2.78%
0.46
33.12%
1.35
194.21%
1.46
8.10%
1.19
18.59%
net income per share
7.86
-
12.42
57.96%
15.37
23.83%
16.95
10.27%
11.94
29.56%
21.62
81.06%
31.47
45.55%
24.86
21.00%
10.44
58.02%
20.97
100.92%
operating cash flow per share
9.90
-
12.45
25.76%
16.11
29.41%
20.71
28.55%
21.41
3.38%
30.20
41.07%
37.83
25.28%
26.29
30.52%
24.41
7.14%
9.53
60.97%
payables turnover
3.90
-
5.11
31.01%
4.64
9.22%
5.28
13.93%
4.12
22.02%
4.90
18.95%
3.68
24.85%
3.97
7.72%
3.58
9.77%
4.64
29.46%
receivables turnover
8.41
-
7.51
10.71%
8.77
16.85%
7.94
9.47%
6.87
13.51%
6.87
0.01%
7.65
11.31%
7.03
8.12%
7.09
0.89%
4.76
32.81%
research and ddevelopement to revenue
0.21
-
0.20
6.33%
0.19
4.17%
0.17
7.83%
0.18
6.53%
0.19
5.15%
0.16
17.84%
0.30
87.14%
0.23
23.27%
0.22
3.71%
0.25
14.14%
return on tangible assets
0.30
-
0.34
13.75%
0.28
19.20%
0.24
13.53%
0.17
30.26%
0.27
60.49%
0.33
21.89%
0.25
22.69%
0.10
61.40%
0.18
83.56%
revenue per share
29.26
-
41.05
40.31%
46.66
13.65%
52.42
12.35%
57.73
10.13%
65.66
13.72%
76.85
17.04%
83.56
8.74%
73.65
11.85%
70.02
4.94%
roe
0.22
-
0.27
25.63%
0.38
39.41%
0.31
19.31%
0.20
33.98%
0.34
68.69%
0.44
29.84%
0.37
15.19%
0.14
62.07%
0.23
60.28%
roic
0.21
-
0.26
26.24%
0.23
10.89%
0.21
11.05%
0.15
27.47%
0.24
56.85%
0.29
24.52%
0.19
34.08%
0.15
24.54%
0.09
35.54%
sales general and administrative to revenue
shareholders equity per share
36.39
-
45.75
25.74%
40.64
11.18%
55.53
36.66%
59.26
6.70%
63.60
7.33%
71.29
12.10%
66.41
6.84%
73.51
10.68%
92.14
25.36%
stock based compensation to revenue
0.02
-
0.02
18.59%
0.01
6.31%
0.01
9.83%
0.01
22.87%
0.01
12.26%
0.01
8.30%
0.01
16.33%
0.02
47.31%
0.02
14.96%
tangible asset value
2.91B
-
5.03B
72.50%
2.63B
47.74%
4.65B
77.11%
4.09B
12.15%
4.21B
2.92%
4.05B
3.60%
1.84B
54.62%
2.98B
61.84%
5.79B
94.45%
tangible book value per share
12.30
-
21.26
72.91%
11.38
46.46%
21.30
87.09%
19.22
9.75%
20.52
6.78%
21.67
5.57%
11.43
47.23%
19.97
74.64%
39.84
99.53%
working capital
1.43B
-
2.45B
71.94%
4.12B
68.07%
5.40B
30.87%
4.51B
16.50%
4.35B
3.54%
3.52B
19.05%
3.14B
10.61%
3.56B
13.15%
6.52B
83.19%

All numbers in USD (except ratios and percentages)